← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Optimer Pharmaceuticals, Inc.
San Diego, CA
$5,333,213
Total funding
7
Grants
Funding over time
peak $1.5M · FY2005–09$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$5,333,213 · 7
By mechanism
R44$4,191,248 · 2
R43$1,141,965 · 5
Investigators at Optimer Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
New Treatment for C. difficile-Associated Diarrhea$1,000,000
R44 · FY2008 · AI
New Treatment for C. difficile-Associated Diarrhea$1,000,000
R44 · FY2007 · AI
New Treatment for C. difficile-Associated Diarrhea$1,000,000
R44 · FY2009 · AI
New Treatment for C. difficile-Associated Diarrhea$734,965
R43 · FY2005 · AI
Macrolide Discovery Through Glycosylation$612,862
R44 · FY2005 · AI
Macrolide Discovery Through Glycosylation$578,386
R44 · FY2006 · AI
Hexosaminidase, a novel target for chondroprotection$107,000
R43 · FY2005 · AR
New Aminoglycosides to Treat Drug-Resistant Bacteria$100,000
R43 · FY2003 · AI
Macrolide Discovery through Glycosylation$100,000
R43 · FY2004 · AI
N-Acetylglucosamine Treatment of Osteoarthritis$100,000
R43 · FY2003 · AG